Showcasing data on our oncolytic viral therapy at AACR 2025
We showcase breakthrough data on our engineered oncolytic viral therapy, a first-in-class for pediatric liver cancer We are excited to share that Humane Genomics is returning to the American Association for Cancer Research (AACR) annual meeting for the third time! With over 23,000 attendees (in 2024), AACR is the largest gathering of cancer researchers, clinicians, survivors, and advocates in the world. It is an honor to be invited back to this prestigious event where we will be showcasing our groundbreaking…